Počet záznamů: 1  

ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance

  1. 1.
    SYSNO ASEP0524939
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
    Tvůrce(i) Drápela, Stanislav (BFU-R) ORCID
    Bouchal, J. (CZ)
    Jolly, M. K. (IN)
    Culig, Z. (CZ)
    Souček, Karel (BFU-R) RID, ORCID
    Celkový počet autorů5
    Číslo článku36
    Zdroj.dok.Frontiers in molecular biosciences
    Roč. 7, MAR 19 2020 (2020)
    Poč.str.10 s.
    Forma vydáníTištěná - P
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovaepithelial-mesenchymal-transition ; negative breast-cancer ; transcription factor ; drug-resistance ; prostate-cancer
    Vědní obor RIVCE - Biochemie
    Obor OECDBiochemistry and molecular biology
    CEPNV17-28518A GA MZd - Ministerstvo zdravotnictví
    NV18-08-00245 GA MZd - Ministerstvo zdravotnictví
    Způsob publikováníOpen access
    Institucionální podporaBFU-R - RVO:68081707
    UT WOS000525671300001
    EID SCOPUS85082693724
    DOI10.3389/fmolb.2020.00036
    AnotaceThe predominant way in which conventional chemotherapy kills rapidly proliferating cancer cells is the induction of DNA damage. However, chemoresistance remains the main obstacle to therapy effectivity. An increasing number of studies suggest that epithelial-to-mesenchymal transition (EMT) represents a critical process affecting the sensitivity of cancer cells to chemotherapy. Zinc finger E-box binding homeobox 1 (ZEB1) is a prime element of a network of transcription factors controlling EMT and has been identified as an important molecule in the regulation of DNA damage, cancer cell differentiation, and metastasis. Recent studies have considered upregulation of ZEB1 as a potential modulator of chemoresistance. It has been hypothesized that cancer cells undergoing EMT acquire unique properties that resemble those of cancer stem cells (CSCs). These stem-like cells manifest enhanced DNA damage response (DDR) and DNA repair capacity, self-renewal, or chemoresistance. In contrast, functional experiments have shown that ZEB1 induces chemoresistance regardless of whether other EMT-related changes occur. ZEB1 has also been identified as an important regulator of DDR by the formation of a ZEB1/p300/PCAF complex and direct interaction with ATM kinase, which has been linked to radioresistance. Moreover, ATM can directly phosphorylate ZEB1 and enhance its stability. Downregulation of ZEB1 has also been shown to reduce the abundance of CHK1, an effector kinase of DDR activated by ATR, and to induce its ubiquitin-dependent degradation. In this perspective, we focus on the role of ZEB1 in the regulation of DDR and describe the mechanisms of ZEB1-dependent chemoresistance.
    PracovištěBiofyzikální ústav
    KontaktJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Rok sběru2021
    Elektronická adresahttps://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=AdvancedSearch&qid=8&SID=D4ZqAnHn6WSkCM83tcu&page=2&doc=20
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.